- Tytuł:
- Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
- Autorzy:
- Źródło:
- In The Lancet Neurology May 2018 17(5):405-415
Czasopismo naukowe